{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/71579696",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/293076727"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#71579696",
  "code": "LD2F.02",
  "source": "http://id.who.int/icd/entity/71579696",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Embryofetopathy due to oral anticoagulant therapy"
  },
  "definition": {
    "@language": "en",
    "@value": "A condition caused by exposure of the embryo or fetus to anticoagulants during the antenatal period. This disease may present with optic nerve anomaly, optic atrophy, anomaly of the papilla, blindness, or choanal atresia."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Embryofetopathy due to oral anticoagulant therapy"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Fetal warfarin syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/1368779017"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Coumarin embryopathy"
      },
      "foundationReference": "http://id.who.int/icd/entity/1368779017"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Vitamin K antagonists embryofetopathy"
      },
      "foundationReference": "http://id.who.int/icd/entity/1368779017"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Dysmorphism due to warfarin"
      },
      "foundationReference": "http://id.who.int/icd/entity/1706829005"
    }
  ]
}